In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus

Journal of General Virology

Volumn 91, Issue 4, 2010, Pages 847-857

  Pavlova, Sophia P ^a   Veits, Jutta ^a   Blohm, Ulrike ^a   Maresch, Christina ^a   Mettenleiter, Thomas C ^a   Fuchs, Walter ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; PROTEIN C; VACCINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CHICKEN; CONJUNCTIVITIS; CONTROLLED STUDY; COUGHING; GENE DELETION; GENE STRUCTURE; GENETIC ENGINEERING; GENETIC TRANSFECTION; GENOMIC FRAGMENT; HEMOPTYSIS; ILTOVIRUS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; KINETICS; LARYNGOTRACHEOBRONCHITIS; MORTALITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; CHICKENS; GENOME, VIRAL; HERPESVIRUS 1, GALLID; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRUS INTERNALIZATION; VIRUS REPLICATION;

ANIMALIA; GALLID HERPESVIRUS 1; GALLUS GALLUS; HERPESVIRIDAE;

EID: 77949537510     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.016634-0     Document Type: Article

References (61)

1. Andreasen, J. R., Jr, Glisson, J. R. & Villegas, P. (1990). Differentiation of vaccine strains and Georgia field isolates of infectious laryngotracheitis virus by their restriction endonuclease fragment patterns. Avian Dis 34, 646-656.
2. Cardin, A. D. & Weintraub, H. J. (1989). Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9, 21-32.
3. Cohen, J. I. & Seidel, K. E. (1994). Absence of varicella-zoster virus (VZV) glycoprotein V does not alter growth of VZV in vitro or sensitivity to heparin. J Gen Virol 75, 3087-3093.
4. Davison, A. J., Eberle, R., Ehlers, B., Hayward, G. S., McGeoch, D. J., Minson, A. C., Pellett, P. E., Roizman, B., Studdert, M. J. & Thiry, E. (2009). The order Herpesvirales. Arch Virol 154, 171-177.
5. Devlin, J. M., Browning, G. F., Hartley, C. A., Kirkpatrick, N. C., Mahmoudian, A., Noormohammadi, A. H. & Gilkerson, J. R. (2006). Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. J Gen Virol 87, 2839-2847.
6. Fahey, K. J. & York, J. J. (1990). The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. J Gen Virol 71, 2401-2405.
7. Frank, M. M. & Fries, L. F. (1991). The role of complement in inflammation and phagocytosis. Immunol Today 12, 322-326.
8. Friedman, H. M. (2003). Immune evasion by herpes simplex virus type 1, strategies for virus survival. Trans Am Clin Climatol Assoc 114, 103-112.
9. Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Seidel, C. A. & Cines, D. B. (1984). Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 309, 633-635.
10. Fuchs, W. & Mettenleiter, T. C. (1996). DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus. J Gen Virol 77, 2221-2229.
11. Fuchs, W. & Mettenleiter, T. C. (1999). DNA sequence of the UL6 to UL20 genes of infectious laryngotracheitis virus and characterization of the UL10 gene product as a nonglycosylated and nonessential virion protein. J Gen Virol 80, 2173-2182.
12. Fuchs, W. & Mettenleiter, T. C. (2005). The nonessential UL49.5 gene of infectious laryngotracheitis virus encodes an O-glycosylated protein which forms a complex with the non-glycosylated UL10 gene product. Virus Res 112, 108-114.
13. Fuchs, W., Ziemann, K., Teifke, J. P., Werner, O. & Mettenleiter, T. C. (2000). The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor. J Gen Virol 81, 627-638.
14. Fuchs, W., Wiesner, D., Veits, J., Teifke, J. P. & Mettenleiter, T. C. (2005). In vitro and in vivo relevance of the infectious laryngotracheitis virus gJ proteins which are expressed from spliced and nonspliced mRNAs. J Virol 79, 705-716.
15. Fuchs, W., Veits, J., Helferich, D., Granzow, H., Teifke, J. P. & Mettenleiter, T. C. (2007). Molecular biology of avian infectious laryngotracheitis virus. Vet Res 38, 261-279.
16. Gruenheid, S., Gatzke, L., Meadows, H. & Tufaro, F. (1993). Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol 67, 93-100.
17. Guy, J. S. & Garcia, M. (2008). Laryngotracheitis. In Diseases of Poultry, 12th edn, pp. 137-152. Edited by Y. M. Saif. Ames, IA: Blackwell Publishing.
18. Guy, J. S., Barnes, H. J. & Smith, L. G. (1991). Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis 35, 348-355.
19. Helferich, D., Veits, J., Mettenleiter, T. C. & Fuchs, W. (2007a). Identification of transcripts and protein products of the UL31, UL37, UL46, UL47, UL48, UL49 and US4 gene homologues of avian infectious laryngotracheitis virus. J Gen Virol 88, 719-731.
20. Helferich, D., Veits, J., Teifke, J. P., Mettenleiter, T. C. & Fuchs, W. (2007b). The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens. J Gen Virol 88, 732-742.
21. Huemer, H. P., Larcher, C., van Drunen Littel-van den Hurk, S. & Babiuk, L. A. (1993). Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host. Arch Virol 130, 353-364.
22. Jarosinski, K. W., Margulis, N. G., Kamil, J. P., Spatz, S. J., Nair, V. K. & Osterrieder, N. (2007). Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J Virol 81, 10575-10587.
23. Johnson, M. A. & Tyack, S. G. (1995). Molecular evolution of infectious laryngotracheitis virus (ILTV; gallid herpesvirus 1): an ancient example of the Alphaherpesviridae? Vet Microbiol 46, 221-231.
24. Kaashoek, M. J., Rijsewijk, F. A., Ruuls, R. C., Keil, G. M., Thiry, E., Pastoret, P. P. & van Oirschot, J. T. (1998). Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine 16, 802-809.
25. Karger, A., Saalmüller, A., Tufaro, F., Banfield, B. W. & Mettenleiter, T. C. (1995). Cell surface proteoglycans are not essential for infection by pseudorabies virus. J Virol 69, 3482-3489.
26. Kawaguchi, T., Nomura, K., Hirayama, Y. & Kitagawa, T. (1987). Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res 47, 4460-4464.
27. Kingsley, D. H. & Keeler, C. L., Jr (1999). Infectious laryngotracheitis virus, an alpha herpesvirus that does not interact with cell surface heparan sulfate. Virology 256, 213-219.
28. Kingsley, D. H., Hazel, J. W. & Keeler, C. L., Jr (1994). Identification and characterization of the infectious laryngotracheitis virus glycoprotein C gene. Virology 203, 336-343.
29. r of 32 kilodaltons. Virus Res 29, 125-140.
30. Kotiw, M., Wilks, C. R. & May, J. T. (1995). The effect of serial in vivo passage on the expression of virulence and DNA stability of an infectious laryngotracheitis virus strain of low virulence. Vet Microbiol 45, 71-80.
31. McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C., McNab, D., Perry, L. J., Scott, J. E. & Taylor, P. (1988). The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69, 1531-1574.
32. McGeoch, D. J., Dolan, A. & Ralph, A. C. (2000). Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol 74, 10401-10406.
33. Mettenleiter, T. C. (1989). Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology 171, 623-625.
34. Mettenleiter, T. C. & Rauh, I. (1990). A glycoprotein gX-βgalactosidase fusion gene as insertional marker for rapid identification of pseudorabies virus mutants. J Virol Methods 30, 55-65.
35. Mettenleiter, T. C., Schreurs, C., Zuckermann, F., Ben-Porat, T. & Kaplan, A. S. (1988). Role of glycoprotein gIII of pseudorabies virus in virulence. J Virol 62, 2712-2717.
36. Mettenleiter, T. C., Zsak, L., Zuckermann, F., Sugg, N., Kern, H. & Ben-Porat, T. (1990). Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. J Virol 64, 278-286.
37. Moffat, J. F., Zerboni, L., Kinchington, P. R., Grose, C., Kaneshima, H. & Arvin, A. M. (1998). Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72, 965-974.
38. Okazaki, K., Matsuzaki, T., Sugahara, Y., Okada, J., Hasebe, M., Iwamura, Y., Ohnishi, M., Kanno, T., Shimizu, M. & other authors (1991). BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology 181, 666-670.
39. Osterrieder, N. (1999). Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. Virus Res 59, 165-177.
40. Pavlova, S. P., Veits, J., Keil, G. M., Mettenleiter, T. C. & Fuchs, W. (2009). Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 27, 773-785.
41. Poulsen, D. J. & Keeler, C. L., Jr (1997). Characterization of the assembly and processing of infectious laryngotracheitis virus glycoprotein B. J Gen Virol 78, 2945-2951.
42. Robbins, A. K., Whealy, M. E., Watson, R. J. & Enquist, L. W. (1986). Pseudorabies virus gene encoding glycoprotein gIII is not essential for growth in tissue culture. J Virol 59, 635-645.
43. Roizman, B., Knipe, D. M. & Whitley, R. J. (2007). Herpes simplex viruses. In Fields Virology, 5th edn, pp. 2501-2601. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
44. Rue, C. A. & Ryan, P. (2003). A role for glycoprotein C in pseudorabies virus entry that is independent of virus attachment to heparan sulfate and which involves the actin cytoskeleton. Virology 307, 12-21 .
45. Sanes, J. R., Rubenstein, J. L. & Nicolas, J. F. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 5, 3133-3142.
46. Schnitzlein, W. M., Winans, R., Ellsworth, S. & Tripathy, D. N. (1995). Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology 209, 304-314.
47. Schreurs, C., Mettenleiter, T. C., Zuckermann, F., Sugg, N. & Ben-Porat, T. (1988). Glycoprotein gIII of pseudorabies virus is multi-functional. J Virol 62, 2251-2257.
48. Sölder, B. M., Schulz, T. F., Hengster, P., Löwer, J., Larcher, C., Bitterlich, G., Kurth, R., Wachter, H. & Dierich, M. P. (1989). HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol Lett 22, 135-145.
49. Spear, P. G., Shieh, M. T., Herold, B. C., WuDunn, D. & Koshy, T. I. (1992). Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol 313, 341-353.
50. Spear, P. G., Eisenberg, R. J. & Cohen, G. H. (2000). Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275, 1-8.
51. Thureen, D. R. & Keeler, C. L., Jr (2006). Psittacid herpesvirus 1 and infectious laryngotracheitis virus: comparative genome sequence analysis of two avian alphaherpesviruses. J Virol 80, 7863-7872.
52. Tischer, B. K., Schumacher, D., Chabanne-Vautherot, D., Zelnik, V., Vautherot, J. F. & Osterrieder, N. (2005). High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro. J Virol 79, 5889-5899.
53. van Oirschot, J. T. (1999). Diva vaccines that reduce virus transmission. J Biotechnol 73, 195-205.
54. Veits, J., Mettenleiter, T. C. & Fuchs, W. (2003a). Five unique open reading frames of infectious laryngotracheitis virus are expressed during infection but are dispensable for virus replication in cell culture. J Gen Virol 84, 1415-1425.
55. Veits, J., Lüschow, D., Kindermann, K., Werner, O., Teifke, J. P., Mettenleiter, T. C. & Fuchs, W. (2003b). Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84, 3343-3352.
56. Veits, J., Köllner, B., Teifke, J. P., Granzow, H., Mettenleiter, T. C. & Fuchs, W. (2003c). Isolation and characterization of monoclonal antibodies against structural proteins of infectious laryngotracheitis virus. Avian Dis 47, 330-342.
57. Welsh, R. M., Jr, Cooper, N. R., Jensen, F. C. & Oldstone, M. B. (1975). Human serum lyses RNA tumour viruses. Nature 257, 612-614.
58. Wild, M. A., Cook, S. & Cochran, M. (1996). A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions. Virus Genes 12, 107-116.
59. Williams, R. A., Bennett, M., Bradbury, J. M., Gaskell, R. M., Jones, R. C. & Jordan, F. T. (1992). Demonstration of sites of latency of infectious laryngotracheitis virus using the polymerase chain reaction. J Gen Virol 73, 2415-2420.
60. Ziemann, K., Mettenleiter, T. C. & Fuchs, W. (1998a). Gene arrangement within the unique long genome region of infectious laryngotracheitis virus is distinct from that of other alphaherpesviruses. J Virol 72, 847-852.
61. Ziemann, K., Mettenleiter, T. C. & Fuchs, W. (1998b). Infectious laryngotracheitis herpesvirus expresses a related pair of unique nuclear proteins which are encoded by split genes located at the right end of the UL genome region. J Virol 72, 6867-6874.